Research programme: HIV vaccine - Etubics CorporationAlternative Names: Preventative HIV-1 vaccine - Etubics
Latest Information Update: 29 Jul 2010
At a glance
- Originator Etubics Corporation
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical HIV-1 infections
Most Recent Events
- 29 Jul 2010 Preclinical development is ongoing in USA (Parenteral)
- 27 Aug 2007 Preclinical trials in HIV-1 infections in USA (unspecified route)